Company news

United Therapeutics Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

United Therapeutics Corporation to Present at the Jefferies Virtual Health Care Conference

May 25, 2020

United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020

May 5, 2020

United Therapeutics Corporation Reports First Quarter 2020 Financial Results

April 28, 2020

United Therapeutics Announces Additional Results From FREEDOM-EV Study Showing The Hemodynamic And Risk Status Reduction Benefits Of Orenitram Treatment In Patients With Pulmonary Arterial Hypertension

April 22, 2020

United Therapeutics Corporation to Report First Quarter 2020 Financial Results Before the Market Opens on Wednesday, April 29, 2020

April 21, 2020

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2019 Financial Results

February 25, 2020

United Therapeutics Corporation To Present At The 40th Annual Cowen And Company Healthcare Conference

February 24, 2020

United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints

February 23, 2020

United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin®

February 23, 2020

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2019 Financial Results Before the Market Opens on Wednesday, February 26, 2020

February 18, 2020

United Therapeutics Defeats Preliminary Injunction Motion In Litigation With Sandoz And RareGen

February 3, 2020

United Therapeutics Announces Study of Unituxin® (dinutuximab) for Small Cell Lung Cancer Did Not Meet Primary Endpoint

February 2, 2020

United Therapeutics Corporation Reports Third Quarter 2019 Financial Results

October 29, 2019

United Therapeutics Corporation to Report Third Quarter 2019 Financial Results Before the Market Opens on Wednesday, October 30, 2019

October 22, 2019

United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study

October 20, 2019

United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review

September 10, 2019

United Therapeutics Corporation To Present At 2019 Wedbush PacGrow Healthcare Conference

August 5, 2019

United Therapeutics Corporation To Report Second Quarter 2019 Financial Results Before The Market Opens On Wednesday, July 31, 2019

July 23, 2019

United Therapeutics Corporation to Present at Goldman Sachs 40th Annual Global Healthcare Conference

June 4, 2019

United Therapeutics Corporation To Present at Jefferies 2019 Healthcare Conference

May 27, 2019

United Therapeutics Announces FDA Approval Of XPS(TM) And Steen Solution(TM) Used To Perform Centralized Ex-Vivo Lung Perfusion Services

April 28, 2019

United Therapeutics Corporation To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019

April 23, 2019

United Therapeutics Issues Statement In Response To Meritless Lawsuit

April 16, 2019

United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint

April 7, 2019

← Newer news releases

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 22 decks. Every deck is listed under its year.